REFERENCES Relationship between the cellular composition of sputum and the cytologic diagnosis of lung cancer

REFERENCES
1. Risse EK, Vooijs GP, van’t Hof MA. Relationship between the cellular
composition of sputum and the cytologic diagnosis of lung cancer. Acta
Cytol 1987;31(2):170–176.
2. Travis WD LJ, Mackay B. Classification, histology, cytology and electron
microscopy. In: HI P, ed. Lung Cancer . 2nd Ed. Philadelphia:
Lippincott Williams and Wilkins, 2000:453–495.
3. Sing A, Freudenberg N, Kortsik C, et al. Comparison of the sensitivity
of sputum and brush cytology in the diagnosis of lung carcinomas. Acta
Cytol 1997;41(2):399–408.
4. de Gracia J, Bravo C, Miravitlles M, et al. Diagnostic value of bronchoalveolar
lavage in peripheral lung cancer. Am Rev Respir Dis
1993;147(3):649–652.
5. Schreiber G, McCrory DC. Performance characteristics of different
modalities for diagnosis of suspected lung cancer: summary of published
evidence. Chest 2003;123(1 Suppl):S115–S128.
6. Wistuba II, Mao L, Gazdar AF. Smoking molecular damage in bronchial
epithelium. Oncogene 2002;21(48):7298–7306.
7. Westra WH, Slebos RJ, Offerhaus GJ, et al. K-ras oncogene activation
in lung adenocarcinomas from former smokers. Evidence that K-ras
mutations are an early and irreversible event in the development of
adenocarcinoma of the lung. Cancer 1993;72(2):432–438.
8. Travis WD, Lubin J, Ries L, et al. United States lung carcinoma incidence
trends: declining for most histologic types among males, increasing
among females. Cancer 1996;77(12):2464–2470.
9. Silverman JF, Geisinger KR. Lung. In: Silverman JF, Geisinger KR,
eds. Fine Needle Aspiration Cytology of the Thorax and Abdomen . Hong
Kong: Churchill Livingstone, 1996:51.
10. Johnston WW, Elson CE. Respiratory tract. In: Bibbo M, ed.
Comprehensive Cytopathology . 2nd Ed. Philadelphia: W.B. Saunders,
1997:325–401.
11. Geisinger KR, Stanley M, Raab SS, et al. Normal pulmonary cytology
and diffuse lung diseases; localized lung diseases. Modern Cytopathology .
Philadelphia: Churchill Livingstone, 2004:361–432.
12. Travis WD, Brambilla E, Muller-Hermelink HK, eds. Pathology and
Genetics of Tumours of the Lung, Pleura, Thymus and Heart . 1st Ed.
Lyon: International Agency for Research on Cancer, 2004:344.
13. Abe S, Ogura S, Nakajima I, et al. Small-cell-type poorly differentiated
squamous cell carcinoma of the lung. Cytologic, immunohistochemical
and nuclear DNA content analysis. Anal Quant Cytol Histol
1990;12(2):73–77.
14. Cohen MH, Gootenberg J, Keegan P, et al. FDA drug approval
summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as
first-line treatment of advanced/metastatic recurrent nonsquamous
non-small cell lung cancer. Oncologist 2007;12(6):713–718.
15. Hsieh RK, Lim KH, Kuo HT, et al. Female sex and bronchioloalveolar
pathologic subtype predict EGFR mutations in non-small cell lung
cancer. Chest 2005;128(1):317–321.
16. Tan D, Li Q, Deeb G, et al. Thyroid transcription factor-1 expression
prevalence and its clinical implications in non-small cell lung cancer: a
high-throughput tissue microarray and immunohistochemistry study.
Hum Pathol 2003;34(6):597–604.
17. Ordonez NG. The diagnostic utility of immunohistochemistry in distinguishing
between epithelioid mesotheliomas and squamous carcinomas
of the lung: a comparative study. Mod Pathol 2006;19(3):417–428.
18. Crapanzano JP, Zakowski MF. Diagnostic dilemmas in pulmonary
cytology. Cancer 2001;93(6):364–375.
19. Lubin JH, Blot WJ. Assessment of lung cancer risk factors by histologic
category. J Natl Cancer Inst 1984;73(2):383–389.
20. Ramalingam S, Pawlish K, Gadgeel S, et al. Lung cancer in young
patients: analysis of a Surveillance, Epidemiology, and End Results
database. J Clin Oncol 1998;16(2):651–657.
21. Terasaki H, Niki T, Matsuno Y, et al. Lung adenocarcinoma with mixed
bronchioloalveolar and invasive components: clinicopathological features,
subclassification by extent of invasive foci, and immunohistochemical
characterization. Am J Surg Pathol 2003;27(7):937–951.
22. Brambilla E, Travis WD, Colby TV, et al. The new World Health
Organization classification of lung tumours. Eur Respir J 2001;18(6):
1059–1068.
23. Auger M, Katz RL, Johnston DA. Differentiating cytological features
of bronchioloalveolar carcinoma from adenocarcinoma of the
lung in fine-needle aspirations: a statistical analysis of 27 cases. Diagn
Cytopathol 1997;16(3):253–257.
24. Holst VA, Finkelstein S, Yousem SA. Bronchioloalveolar adenocarcinoma
of lung: monoclonal origin for multifocal disease. Am J Surg
Pathol 1998;22(11):1343–1350.
25. MacDonald LL, Yazdi HM. Fine-needle aspiration biopsy of bronchioloalveolar
carcinoma. Cancer 2001;93(1):29–34.
26. Ohori NP, Santa Maria EL. Cytopathologic diagnosis of bronchioloalveolar
carcinoma: does it correlate with the 1999 World Health
Organization definition? Am J Clin Pathol 2004;122(1):44–50.
27. Vazquez MF, Koizumi JH, Henschke CI, et al. Reliability of cytologic
diagnosis of early lung cancer. Cancer 2007;111(4):252–258.
28. Saleh HA, Haapaniemi J, Khatib G, et al. Bronchioloalveolar carcinoma:
diagnostic pitfalls and immunocytochemical contribution.
Diagn Cytopathol 1998;18(4):301–306.
29. Yim J, Zhu LC, Chiriboga L, et al. Histologic features are important
prognostic indicators in early stages lung adenocarcinomas. Mod Pathol
2007;20(2):233–241.
30. Rusch VW, Tsuchiya R, Tsuboi M, et al. Surgery for bronchioloalveolar
carcinoma and “very early” adenocarcinoma: an evolving standard of
care? J Thorac Oncol 2006;1(9 Suppl):S27–S31.
31. Wei EX, Anga AA, Martin SS, et al. EGFR expression as an ancillary
tool for diagnosing lung cancer in cytology specimens. Mod Pathol
2007;20(9):905–913.
32. Zudaire I, Lozano MD, Vazquez MF, et al. Molecular characterization
of small peripheral lung tumors based on the analysis of fine needle
aspirates. Histol Histopathol 2008;23(1):33–40.
33. Garfield DH, Cadranel JL, Wislez M, et al. The bronchioloalveolar
carcinoma and peripheral adenocarcinoma spectrum of diseases.
J Thorac Oncol 2006;1(4):344–359.
34. Chen KT. Psammoma bodies in fine-needle aspiration cytology of papillary
adenocarcinoma of the lung. Diagn Cytopathol 1990;6(4):271–274.
35. Duncan LD, Jacob S, Atkinson S. Fine needle aspiration cytologic
findings of micropapillary carcinoma in the lung: a case report. Acta
Cytol 2007;51(4):605–609.
36. Kaufmann O, Dietel M. Thyroid transcription factor-1 is the superior
immunohistochemical marker for pulmonary adenocarcinomas
and large cell carcinomas compared to surfactant proteins A and B.
Histopathology 2000;36(1):8–16.
37. Chhieng DC, Cangiarella JF, Zakowski MF, et al. Use of thyroid transcription
factor 1, PE-10, and cytokeratins 7 and 20 in discriminating
between primary lung carcinomas and metastatic lesions in fine-needle
aspiration biopsy specimens. Cancer 2001;93(5):330–336.
38. Dabbs DJ, Landreneau RJ, Liu Y, et al. Detection of estrogen receptor
by immunohistochemistry in pulmonary adenocarcinoma. Ann Thorac
Surg 2002;73(2):403–405; discussion 406.
39. Mazziotta RM, Borczuk AC, Powell CA, et al. CDX2 immunostaining
as a gastrointestinal marker: expression in lung carcinomas is a potential
pitfall. Appl Immunohistochem Mol Morphol 2005;13(1):55–60.
40. Ng WK, Fu KH, Wang E, et al. Sclerosing hemangioma of lung: a close
cytologic mimicker of pulmonary adenocarcinoma. Diagn Cytopathol
2001;25(5):316–320.
41. Saqi A, Shaham D, Scognamiglio T, et al. Incidence and cytological
features of pulmonary hamartomas indeterminate on CT scan.
Cytopathology 2008;19(3):185–191.
42. Flieder DB. Neuroendocrine tumors of the lung: recent developments
in histopathology. Curr Opin Pulm Med 2002;8(4):275–280.
43. Collins BT, Cramer HM. Fine needle aspiration cytology of carcinoid
tumors. Acta Cytol 1996;40(4):695–707.
44. Anderson C, Ludwig ME, O’Donnell M, et al. Fine needle aspiration cytology
of pulmonary carcinoid tumors. Acta Cytol 1990;34(4):505–510.
45. Yao D DR, Yankelevitz D, Vazquez MF. Prominent vascularity distinguishes
typical carcinoid and atypical carcinoid from high grade neuroendocrine
carcinoma on transthoracic fine needle aspirates. Mod Pathol
2002;15:94A.
46. Mitchell ML, Parker FP. Capillaries. A cytologic feature of pulmonary
carcinoid tumors. Acta Cytol 1991;35(2):183–185.
47. Renshaw AA, Haja J, Lozano RL, et al. Distinguishing carcinoid
tumor from small cell carcinoma of the lung: correlating cytologic
features and performance in the College of American Pathologists
Non-Gynecologic Cytology Program. Arch Pathol Lab Med 2005;
129(5):614–618.
48. Evans H, Blaney R. Pulmonary carcinoid with papillary structure: report
of a case with fine-needle aspiration cytology. Diagn Cytopathol
1994;11(2):178–181.
49. Sturm N, Rossi G, Lantuejoul S, et al. Expression of thyroid transcription
factor-1 in the spectrum of neuroendocrine cell lung proliferations
with special interest in carcinoids. Hum Pathol 2002;33(2):175–182.
50. Folpe AL, Gown AM, Lamps LW, et al. Thyroid transcription factor-1:
immunohistochemical evaluation in pulmonary neuroendocrine tumors.
Mod Pathol 1999;12(1):5–8.
51. Rusch VW, Klimstra DS, Venkatraman ES. Molecular markers help
characterize neuroendocrine lung tumors. Ann Thorac Surg 1996;
62(3):798–809; discussion 809–810.
52. Aslan DL, Gulbahce HE, Pambuccian SE, et al. Ki-67 immunoreactivity
in the differential diagnosis of pulmonary neuroendocrine neoplasms
in specimens with extensive crush artifact. Am J Clin Pathol
2005;123(6):874–878.
53. Saqi A, Oster MW, Vazquez MF. Metastatic mammary carcinomas
with endocrine features: potential diagnostic pitfalls. Diagn Cytopathol
2005;33(1):49–53.
54. Nicholson SA, Beasley MB, Brambilla E, et al. Small cell lung carcinoma
(SCLC): a clinicopathologic study of 100 cases with surgical
specimens. Am J Surg Pathol 2002;26(9):1184–1197.
55. Mullins RK, Thompson SK, Coogan PS, et al. Paranuclear blue
inclusions: an aid in the cytopathologic diagnosis of primary and
metastatic pulmonary small-cell carcinoma. Diagn Cytopathol 1994;
10(4):332–335.
56. Wittchow R, Laszewski M, Walker W, et al. Paranuclear blue inclusions
in metastatic undifferentiated small cell carcinoma in the bone marrow.
Mod Pathol 1992;5(5):555–558.
57. Delgado PI, Jorda M, Ganjei-Azar P. Small cell carcinoma versus other
lung malignancies: diagnosis by fine-needle aspiration cytology. Cancer
2000;90(5):279–285.
58. Jiang SX, Kameya T, Shoji M, et al. Large cell neuroendocrine carcinoma
of the lung: a histologic and immunohistochemical study of 22
cases. Am J Surg Pathol 1998;22(5):526–537.
59. Travis WD, Linnoila RI, Tsokos MG, et al. Neuroendocrine tumors
of the lung with proposed criteria for large-cell neuroendocrine carcinoma.
An ultrastructural, immunohistochemical, and flow cytometric
study of 35 cases. Am J Surg Pathol 1991;15(6):529–553.
60. Wiatrowska BA, Krol J, Zakowski MF. Large-cell neuroendocrine carcinoma
of the lung: proposed criteria for cytologic diagnosis. Diagn
Cytopathol 2001;24(1):58–64.
61. Yang YJ, Steele CT, Ou XL, et al. Diagnosis of high-grade pulmonary
neuroendocrine carcinoma by fine-needle aspiration biopsy: nonsmallcell
or small-cell type? Diagn Cytopathol 2001;25(5):292–300.
62. Marmor S, Koren R, Halpern M, et al. Transthoracic needle biopsy in
the diagnosis of large-cell neuroendocrine carcinoma of the lung. Diagn
Cytopathol 2005;33(4):238–243.
63. Sturm N, Lantuéjoul S, Laverriere MH, et al. Thyroid transcription
factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid
and large-cell neuroendocrine carcinomas of the lung. Hum Pathol
2001;32(9):918–925.
64. Travis WD, Rush W, Flieder DB, et al. Survival analysis of 200 pulmonary
neuroendocrine tumors with clarification of criteria for atypical
carcinoid and its separation from typical carcinoid. Am J Surg Pathol
1998;22(8):934–944.
65. Molina JR, Aubry MC, Lewis JE, etal. Primary salivary gland-type lung
cancer: spectrum of clinical presentation, histopathologic and prognostic
factors. Cancer 2007;110(10):2253–2259.
66. Daneshbod Y, Modjtahedi E, Atefi S, et al. Exfoliative cytologic findings
of primary pulmonary adenoid cystic carcinom: a report of 2 cases with
a review of the cytologic features. Acta Cytol 2007;51(4):558–562.
67. Segletes LA, Steffee CH, Geisinger KR. Cytology of primary pulmonary
mucoepidermoid and adenoid cystic carcinoma. A report of four
cases. Acta Cytol 1999;43(6):1091–1097.
68. Qiu S, Nampoothiri MM, Zaharopoulos P, et al. Primary pulmonary
adenoid cystic carcinoma: report of a case diagnosed by fine-needle
aspiration cytology. Diagn Cytopathol 2004;30(1):51–56.
69. Moran CA. Primary salivary gland-type tumors of the lung. Semin
Diagn Pathol 1995;12(2):106–122.
70. Shilo K, Foss RD, Franks TJ, et al. Pulmonary mucoepidermoid carcinoma
with prominent tumor-associated lymphoid proliferation. Am J
Surg Pathol 2005;29(3):407–411.
71. Heitmiller RF, Mathisen DJ, Ferry JA, et al. Mucoepidermoid lung
tumors. Ann Thorac Surg 1989;47(3):394–399.
72. Sakamoto H, Uda H, Tanaka T, et al. Pleomorphic adenoma in the
periphery of the lung. Report of a case and review of the literature. Arch
Pathol Lab Med 1991;115(4):393–396.
73. Jay SJ, Wehr K, Nicholson DP, et al. Diagnostic sensitivity and
specificity of pulmonary cytology: comparison of techniques used
in conjunction with flexible fiber optic bronchoscopy. Acta Cytol
1980;24(4):304–312.
74. Glatz K, Savic S, Glatz D, et al. An online quiz uncovers limitations
of morphology in equivocal lung cytology. Cancer 2006;108(6):
480–487.
75. Kornstein MJ, Byrne SP. The medicolegal aspect of error in pathology:
a search of jury verdicts and settlements. Arch Pathol Lab Med
2007;131(4):615–618.
76. Afify A, Davila RM. Pulmonary fine needle aspiration biopsy. Assessing
the negative diagnosis. Acta Cytol 1999;43(4):601–604.
77. Zakowski MF, Gatscha RM, Zaman MB. Negative predictive value
of pulmonary fine needle aspiration cytology. Acta Cytol 1992;36(3):
283–286.
78. Silverman JF. Inflammatory and neoplastic processes of the lung:
differential diagnosis and pitfalls in FNA biopsies. Diagn Cytopathol
1995;13(5):448–462.
79. Policarpio-Nicolas ML, Wick MR. False-positive interpretations in respiratory
cytopathology: exemplary cases and literature review. Diagn
Cytopathol 2008;36(1):13–19.
80. Naryshkin S, Young NA. Respiratory cytology: a review of nonneoplastic
mimics of malignancy. Diagn Cytopathol 1993;9(1):89–97.
81. Ritter JH, Wick MR, Reyes A, et al. False-positive interpretations
of carcinoma in exfoliative respiratory cytology. Report of
two cases and a review of underlying disorders. Am J Clin Pathol
1995;104(2):133–140.
82. Kobashi Y, Fukuda M, Nakata M, et al. Coexistence of metastatic lung
cancer and pulmonary tuberculosis diagnosed in the same cavity. Int J
Clin Oncol 2005;10(5):366–370.
83. Kurasawa T, Takahashi M, Kuze F, et al. A clinical study on coexistence
of active pulmonary tuberculosis and lung cancer [in Japanese].
Kekkaku 1992;67(2):119–125.
84. Flieder DB, Moran CA. Pulmonary dirofilariasis: a clinicopathologic
study of 41 lesions in 39 patients. Hum Pathol 1999;30(3):251–256.
85. Foroulis CN, Khaldi L, Desimonas N, et al. Pulmonary dirofilariasis
mimicking lung tumor with chest wall and mediastinal invasion.
Thorac Cardiovasc Surg 2005;53(3):173–175.
86. Akaogi E, Ishibashi O, Mitsui K, et al. Pulmonary dirofilariasis cytologically
mimicking lung cancer. A case report. Acta Cytol 1993;
37(4):531–534.
87. Risher WH, Crocker EF Jr, Beckman EN, et al. Pulmonary dirofilariasis.
The largest single-institution experience. J Thorac Cardiovasc Surg
1989;97(2):303–308.
88. Grunze H. Cytologic diagnosis of tumors of the chest. Acta Cytol 1973;
17(2):148–159.
89. Linssen KC, Jacobs JA, Poletti VE, et al. Reactive type II pneumocytes
in bronchoalveolar lavage fluid. Acta Cytol 2004;48(4):497–504.
90. Awasthi A, Malhotra P, Gupta N, et al. Pitfalls in the diagnosis
of Wegener’s granulomatosis on fine needle aspiration cytology.
Cytopathology 2007;18(1):8–12.
91. Williamson JD, Murphree SS, Wills-Frank L. Atypical squamous cells
as a diagnostic pitfall in pulmonary Wegener’s granulomatosis. A case
report. Acta Cytol 2002;46(3):571–576.
92. Pitman MB, Szyfelbein WM, Niles J, et al. Clinical utility of fine needle
aspiration biopsy in the diagnosis of Wegener’s granulomatosis. A
report of two cases. Acta Cytol 1992;36(2):222–229.
93. Grotte D, Stanley MW, Swanson PE, et al. Reactive type II pneumocytes
in bronchoalveolar lavage fluid from adult respiratory distress syndrome
can be mistaken for cells of adenocarcinoma. Diagn Cytopathol
1990;6(5):317–322.
94. Stanley MW, Henry-Stanley MJ, Gajl-Peczalska KJ, et al.
Hyperplasia of type II pneumocytes in acute lung injury. Cytologic
findings of sequential bronchoalveolar lavage. Am J Clin Pathol
1992;97(5):669–677.
95. McKee G, Parums DV. False-positive cytodiagnosis in fibrosing alveolitis.
Acta Cytol 1990;34(1):105–107.
96. Beskow CO, Drachenberg CB, Bourquin PM, et al. Diffuse alveolar
damage. Morphologic features in bronchoalveolar lavage fluid. Acta
Cytol 2000;44(4):640–646.
97. Kaminsky DA, Leiman G. False-positive sputum cytology in a case of
pulmonary infarction. Respir Care 2004;49(2):186–188.
98. Lawther RE, Graham AN, McCluggage WG, et al. Pulmonary infarct
cytologically mimicking adenocarcinoma of the lung. Ann Thorac Surg
2002;73(6):1964–1965.
99. Bewtra C, Dewan N, O’Donahue WJ Jr. Exfoliative sputum cytology
in pulmonary embolism. Acta Cytol 1983;27(5):489–496.
100. Scoggins WG, Smith RH, Frable WJ, et al. False-positive cytologicial
diagnosis of lung carcinoma in patients with pulmonary infarcts. Ann
Thorac Surg 1977;24(5):474–480.
101. Tanimura S, Tomoyasu H, Bamba J, et al. Three cases of pulmonary
embolism incorrectly diagnosed as lung cancer [in Japanese]. Jpn J
Thorac Cardiovasc Surg 1998;46(11):1137–1140.
102. Naryshkin S, Bedrossian CW. Selected mimics of malignancy in sputum
and bronchoscopic cytology specimens. Diagn Cytopathol 1995;
13(5):443–447.
103. Zaman SS, van Hoeven KH, Slott S, et al. Distinction between
bronchioloalveolar carcinoma and hyperplastic pulmonary proliferations:
a cytologic and morphometric analysis. Diagn Cytopathol 1997;
16(5):396–401.
104. Naylor B, Railey C. A pitfall in the cytodiagnosis of sputum of asthmatics.
J Clin Pathol 1964;17:84–89.
105. Koss LG SW, Wiodzimierz O. Cytologic Interpretation and Histologic
Basis . New York: Igaku-Shoin, 1992:474–530.
106. Hughes JH, Young NA, Wilbur DC, et al. Fine-needle aspiration of pulmonary
hamartoma: a common source of false-positive diagnoses in the
College of American Pathologists Interlaboratory Comparison Program
in Nongynecologic Cytology. Arch Pathol Lab Med 2005;129(1):19–22.
107. Yüksel M, Akgül AG, Evman S, et al. Suture and stapler granulomas: a
word of caution. Eur J Cardiothorac Surg 2007;31(3):563–565.
108. Berman JJ, Murray RJ, Lopez-Plaza IM. Widespread posttracheostomy
atypia simulating squamous cell carcinoma. A case report. Acta Cytol
1991;35(6):713–716.
109. Weaver KM, Novak PM, Naylor B. Vegetable cell contaminants in cytologic
specimens: their resemblance to cells associated with various
normal and pathologic states. Acta Cytol 1981;25(3):210–214.
110. Sharma GK, Talbot IC. Pulmonary megakaryocytes: “missing link”
between cardiovascular and respiratory disease? J Clin Pathol 1986;
39(9):969–976.